BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Diabetes mellitus
,
Hippocampus
,
Autoimmunity
,
Fenofibrate
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rad50 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer A549 cells with PARP3 knockout and treated with pyridostatin
Lung cancer NCI-H1299 cells 48hr with IQGAP3 siRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Mre11-Rad50: the DNA end game.
Mre11-Rad50 oligomerization promotes DNA double-strand break repair.
Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combin…
Double heterozygous mutation in RAD50 and ATM genes in a Peruvian family with five cancer types: a c…
Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patient…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excret…
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patient…
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have…
Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ